EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS (Q27322781)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS
scientific article

    Statements

    EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS (English)
    0 references
    0 references
    Claire E Le Pichon
    0 references
    Sara L Dominguez
    0 references
    Hilda Solanoy
    0 references
    Hai Ngu
    0 references
    Nicholas Lewin-Koh
    0 references
    Mark Chen
    0 references
    Ryan Watts
    0 references
    Kimberly Scearce-Levie
    0 references
    2013
    0 references
    0 references
    8
    0 references
    4
    0 references
    e62342
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit